Affiliation: University of Sydney
- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsFiona Turnbull
Blood Pressure Lowering Treatment Trialists Collaboration, The George Institute for International Health, University of Sydney, PO Box 576, Newtown, Sydney, New South Wales 2042, Australia
Lancet 362:1527-35. 2003....
- Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trialMeg J Jardine
The George Institute for Global Health, Sydney, Australia Concord Repatriation General Hospital, Sydney, Australia
J Am Coll Cardiol 56:956-65. 2010..The purpose of this study was to determine the benefit and risk associated with antiplatelet therapy in the chronic kidney disease (CKD) population...
- Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trialsFiona Turnbull
Blood Pressure Lowering Treatment Trialists Collaboration, The George Institute for International Health, University of Sydney, Sydney, NSW, Australia
Eur Heart J 29:2669-80. 2008..The aims of these overview analyses were to quantify the effects of blood pressure-lowering treatment in each sex and to determine if there are important differences in the proportional benefits of treatment between men and women...
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv
The George Institute for Global Health, The University of Sydney, Sydney, Australia
PLoS Med 9:e1001293. 2012..We did a systematic review to assess the effects of intensive BP lowering on vascular, eye, and renal outcomes...
- The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clockAndre Pascal Kengne
The George Institute for International Health, The University of Sydney, Camperdown, Sydney, NSW, Australia
Prog Cardiovasc Dis 53:45-51. 2010..Lines of investigation regarding cardiovascular health in this population are still wide open, and the Framingham Study continues to be part of this journey...
- Blood pressure and cardiovascular disease: tracing the steps from FraminghamFiona Turnbull
Cardiovascular Division, The George Institute for International Health, Camperdown, NSW 2050, Australia
Prog Cardiovasc Dis 53:39-44. 2010..Much of our current understanding of the role blood pressure in cardiovascular disease can be attributed to decades of high quality research from Framingham...
- Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART studyFiona Turnbull
The George Institute for Global Health, University of Sydney, New South Wales, Australia
Eur J Cardiovasc Prev Rehabil 18:498-503. 2011....
- The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsSebastien Czernichow
The George Institute, Sydney, Australia
J Hypertens 29:4-16. 2011..The objective was to compare the risk reductions achieved by different blood pressure-lowering regimens among individuals with different baseline blood pressures...
- System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysisIsuru Ranasinghe
Cardiovascular Division, George Institute For Global Health, University of Sydney, Sydney, Australia
Circ Cardiovasc Qual Outcomes 7:209-16. 2014..We performed a qualitative evaluation to examine the system-level barriers to implementing clinical pathways in the dynamic healthcare environment of China...
- Effectiveness of blood pressure lowering: evidence-based comparisons between men and womenFiona Turnbull
Population Health Research, Cardiovascular Division, The George Institute for International Health, Sydney, Australia
Expert Rev Cardiovasc Ther 8:199-209. 2010..Underestimation of cardiovascular risk and supoptimal therapy are more likely to account for poorer outcomes among women. These differences highlight the importance of global initiatives such as 'Go Red for Women'...
- Clinical pathways for acute coronary syndromes in China: protocol for a hospital quality improvement initiativeYe Rong
George Institute For Global Health, The University of Sydney, Missenden Road, Sydney, Australia
Crit Pathw Cardiol 9:134-9. 2010....
- Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication complianceKharis Burns
The George Institute for Global Health, University of Sydney, Camperdown, NSW, Australia
Int J Pharm Pract 20:155-63. 2012..The objective was to identify the main perceived barriers to compliance and to investigate pharmacists' opinions regarding the routine use of a cardiovascular polypill...
- The relationship between proteinuria and coronary risk: a systematic review and meta-analysisVlado Perkovic
The George Institute for International Health, Sydney, New South Wales, Australia
PLoS Med 5:e207. 2008..We therefore undertook a systematic review of published cohort studies aiming to provide a reliable estimate of the strength of association between proteinuria and coronary heart disease...
- Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsFiona Turnbull
The George Institute for International Health, University of Sydney, New South Wales, Australia
Arch Intern Med 165:1410-9. 2005..The overviews reported herein were performed to formally compare the effects on cardiovascular events and death of different BP-lowering regimens in individuals with and without diabetes...
- Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) studyYufang Bi
The George Institute for International Health, Sydney, Australia
Am Heart J 157:509-516.e1. 2009..Although there is strong evidence for the use of antiplatelet, blood pressure-lowering, and lipid-lowering therapy in patients with acute coronary syndromes, the extent to which these medications are used in China remains uncertain...
- Managing cardiovascular risk factors: the gap between evidence and practiceFiona Turnbull
George Institute for International Health, University of Sydney, Australia
PLoS Med 2:e131. 2005
- Acupuncture for blood pressure lowering: needling the truthFiona Turnbull
Circulation 115:3048-9. 2007